LeonaBio (LONA) Cash from Operations (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash from Operations data on file, last reported at 20903000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 42.54% year-over-year to 20903000.0 in Q1 2026; TTM through Mar 2026 was 51967000.0, a 39.6% increase from a year earlier, with the FY2025 full-year figure at 45729000.0, up 52.94% from the prior year.
• Cash from Operations for Q1 2026 stood at 20903000.0, down from 19397000.0 in the prior quarter.
• Over the last five years, Cash from Operations for LONA reached as high as 4668000.0 in Q3 2025 and fell as low as 26293000.0 in Q4 2023.
• Historically, Cash from Operations has averaged 19824941.18 across 5 years, with a median of 21640000.0 in 2022.
• Across the five-year window, Cash from Operations sank 154.07% in 2022 and jumped 79.72% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 15667000.0 in 2022, then tumbled by 67.82% to 26293000.0 in 2023, then advanced by 1.06% to 26013000.0 in 2024, then climbed by 25.43% to 19397000.0 in 2025, then declined by 7.76% to 20903000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 20903000.0 in Q1 2026, 19397000.0 in Q4 2025, and 4668000.0 in Q3 2025.